IL-1β and ADAM17 are central regulators of β-defensin expression in Candida esophagitis.

Authors:
Rene Pahl, Gabriele Brunke, Nadine Steubesand, Sabine Schubert, Martina Böttner, Thilo Wedel, Christian Jürgensen, Jochen Hampe, Heiner Schäfer, Sebastian Zeissig, Stefan Schreiber, Philip Rosenstiel, Karina Reiss, Alexander Arlt
Year of publication:
2011
Volume:
300
Issue:
4
Issn:
0193-1857
Journal title abbreviated:
AM J PHYSIOL-GASTR L
Journal title long:
American journal of physiology Gastrointestinal and liver physiology
Impact factor:
3.297
Abstract: 
Candida albicans resides on epithelial surfaces as part of the physiological microflora. However, under certain conditions, it may cause life-threatening infections, including Candida sepsis. We have recently shown that human β-defensins (hBDs) hBD-2 and hBD-3 are upregulated in Candida esophagitis and that this antifungal host response is distinctly regulated by NF-κB and MAPK/activator protein-1 (AP-1) pathways. Here, we show that C. albicans induces hBD-2 through an autocrine IL-1β loop and that activation of the epidermal growth factor receptor (EGFR) by endogenous transforming growth factor-α (TGF-α) is a crucial event in the induction of hBD-3. To further dissect upstream signaling events, we investigated expression of the central sheddases for EGFR ligands ADAM10 and ADAM17 in the healthy and infected esophagus. Next, we used pharmaceutical inhibitors and small-interfering RNA-mediated knock down of ADAM10 and ADAM17 to reveal that ADAM17-induced shedding of TGF-α is a crucial step in the induction of hBD-3 expression in response to Candida infection. In conclusion, we describe for the first time an autocrine IL-1β loop responsible for the induction of hBD-2 expression and an ADAM17-TGF-α-EGFR-MAPK/AP-1 pathway leading to hBD-3 upregulation in the course of a Candida infection of the esophagus.